Kevin Zhang

Kevin Zhang started their work experience as an Associate at Upfront Ventures in October 2012 and later became a Senior Associate in November 2014. Kevin then served as a Principal starting in October 2015 before becoming a Partner in December 2016. Upfront Ventures is an investment firm focused on supporting innovative startups in various technology sectors. In addition to their role at Upfront Ventures, Kevin Zhang also holds positions as a Seed Lead and Board Member in multiple companies including CertifyOS, Omni Creator Products, Pragma Platform, Switch Therapeutics, Path, Stray Bombay Company, Reveleer, Tellie, and Canvas Medical.

Kevin Zhang attended Harvard University from 2005 to 2009, where they obtained their AB degree in Biology with a minor in Psychology.